RJA
AMSGP

Raymond James & Associates’s Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 AMSGP Stock Holding History

Raymond James & Associates’s Portfolio AMSGP Stock Details AMSGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,600
Closed -$203K – 3450
2016
Q3 		$203K Sell
1,600
-400
-20% -$52K ﹤0.01% 2843
2016
Q2 		$289K Sell
2,000
-140
-7% -$20.3K ﹤0.01% 2430
2016
Q1 		$305K Buy
+2,140
New +$288K ﹤0.01% 2319

Raymond James & Associates's AMSGP Position: Q4 2016 in Review

Raymond James & Associates sold out of Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 (AMSGP) in Q4 2016, closing a stake of 1,600 shares — an estimated $203K sold.

Raymond James & Associates first reported a position in AMSGP in Q1 2016 and held it in 3 quarters. The position peaked at $305K in Q1 2016. 0 funds tracked by Wall St. Rank hold AMSGP as of Q4 2016.

  • Raymond James & Associates reported no remaining Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position as of Q4 2016 after selling out during the quarter.
  • Raymond James & Associates sold 1,600 Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 shares in Q4 2016, an estimated $203K.
  • Raymond James & Associates first reported a position in Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 in Q1 2016 and held it in 3 quarters.
  • Raymond James & Associates's Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 position peaked at $305K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1 as of Q4 2016.

Based on Raymond James & Associates's 13F filing for Q4 2016, filed 14 Feb 2017.